Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 2
Submit an article Journal homepage
1,833
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

RASA4 inhibits the HIFα signaling pathway to suppress proliferation of cervical cancer cells

Junying Chena Department of Gynecology, The First Affiliated Hospital of Guangxi Medical University, Nanning City, ChinaCorrespondence[email protected]
View further author information
,
Jinbing Huanga Department of Gynecology, The First Affiliated Hospital of Guangxi Medical University, Nanning City, ChinaView further author information
,
Qiaoqiao Huanga Department of Gynecology, The First Affiliated Hospital of Guangxi Medical University, Nanning City, ChinaView further author information
,
Ji Lia Department of Gynecology, The First Affiliated Hospital of Guangxi Medical University, Nanning City, China;b Department of Obstetrics and Gynecology, The People’s Hospital of Cenxi City, Cenxi city, ChinaView further author information
,
Erling Chena Department of Gynecology, The First Affiliated Hospital of Guangxi Medical University, Nanning City, ChinaView further author information
&
Wensheng Xua Department of Gynecology, The First Affiliated Hospital of Guangxi Medical University, Nanning City, ChinaCorrespondence[email protected]
View further author information
Pages 10723-10733 | Received 22 Aug 2021, Accepted 29 Oct 2021, Published online: 06 Dec 2021

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer. Lancet. 2019;393(10167):169–182.
  • Benson R, Pathy S, Kumar L, et al. Locally advanced cervical cancer - neoadjuvant chemotherapy followed by concurrent chemoradiation and targeted therapy as maintenance: a phase II study. J Cancer Res Ther. 2019;15(6):1359–1364.
  • Marquina G, Manzano A, Casado A. Targeted agents in cervical cancer: beyond bevacizumab. Curr Oncol Rep. 2018;20(5):40.
  • Zhou B, Der CJ, Cox AD. The role of wild type RAS isoforms in cancer. Semin Cell Dev Biol. 2016;58:60–69.
  • Prior IA, Hood FE, Hartley JL. The frequency of Ras mutations in cancer. Cancer Res. 2020;80(14):2969–2974.
  • Hu YC, Wang AM, Lu JK, et al. Long noncoding RNA HOXD-AS1 regulates proliferation of cervical cancer cells by activating Ras/ERK signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(22):5049–5055.
  • Kang AR, An HT, Ko J, et al. Ataxin-1 is involved in tumorigenesis of cervical cancer cells via the EGFR-RAS-MAPK signaling pathway. Oncotarget. 2017;8(55):94606–94618.
  • Li L, Fan Y, Huang X, et al. Tumor suppression of Ras GTPase-Activating protein RASA5 through antagonizing Ras signaling perturbation in carcinomas. iScience. 2019;21:1–18.
  • Wang Y, Qi YX, Qi Z, et al. TRPC3 regulates the proliferation and apoptosis resistance of triple negative breast cancer cells through the TRPC3/RASA4/MAPK pathway. Cancers (Basel). 2019;11:4.
  • Poetsch AR, Lipka DB, Witte T, et al. RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia. Epigenetics. 2014;9(9):1252–1260.
  • Jing X, Yang F, Shao C, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157.
  • Saha SK, Islam SMR, Abdullah-Al-Wadud M, et al. Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer. J Clin Med. 2019;8:3.
  • Kumar S, Wang G, Liu W, et al. Hypoxia-induced mitogenic factor promotes cardiac hypertrophy via calcium-dependent and hypoxia-inducible Factor-1alpha mechanisms. Hypertension. 2018;72(2):331–342.
  • Chen S, Li F, Xu D, et al. The function of RAS mutation in cancer and advances in its drug research. Curr Pharm Des. 2019;25(10):1105–1114.
  • Lanfredini S, Thapa A, O’Neill E. RAS in pancreatic cancer. Biochem Soc Trans. 2019;47(4):961–972.
  • Masliah-Planchon J, Garinet S, Pasmant E. RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action. Oncotarget. 2016;7(25):38892–38907.
  • Lin H, Fan X, He L, et al. Methylation patterns of RASA3 associated with clinicopathological factors in hepatocellular carcinoma. J Cancer. 2018;9(12):2116–2122.
  • Arafeh R, Qutob N, Emmanuel R, et al. Recurrent inactivating RASA2 mutations in melanoma. Nat Genet. 2015;47(12):1408–1410.
  • Stone L. Hypoxia-related gene panel is prognostic. Nat Rev Urol. 2018;15(7):398.
  • Bai H, Ge S, Lu J, et al. Hypoxia inducible factor-1alpha-mediated activation of survivin in cervical cancer cells. J Obstet Gynaecol Res. 2013;39(2):555–563.
  • Su X, Lang C, Luan A, et al. MiR-200a promotes proliferation of cervical cancer cells by regulating HIF-1alpha/VEGF signaling pathway. J BUON. 2020;25(4):1935–1940.
  • Zhu J, Cheng X, Xie R, et al. Genetic association between the HIF-1alpha P582S polymorphism and cervical cancer risk: a meta analysis. Int J Clin Exp Pathol. 2014;7(9):6085–6090.
  • Yang A, Li MY, Zhang ZH, et al. Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity. J Ethnopharmacol. 2021;273:113598.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.